X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (46138) 46138
Magazine Article (203) 203
Book Chapter (140) 140
Newsletter (132) 132
Publication (64) 64
Dissertation (45) 45
Book Review (28) 28
Book / eBook (22) 22
Conference Proceeding (19) 19
Reference (10) 10
Newspaper Article (8) 8
Web Resource (7) 7
Transcript (3) 3
Data Set (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31246) 31246
male (18985) 18985
angiotensin-converting enzyme inhibitors - therapeutic use (18588) 18588
female (14196) 14196
animals (12360) 12360
middle aged (10331) 10331
hypertension - drug therapy (9090) 9090
aged (8974) 8974
angiotensin-converting enzyme inhibitors - pharmacology (8870) 8870
hypertension (8057) 8057
cardiac & cardiovascular systems (7074) 7074
rats (6741) 6741
adult (6547) 6547
blood pressure - drug effects (6374) 6374
pharmacology & pharmacy (5994) 5994
angiotensin-converting enzyme inhibitors (5324) 5324
antihypertensive agents - therapeutic use (5289) 5289
peripheral vascular disease (4966) 4966
angiotensin (4848) 4848
heart failure - drug therapy (4572) 4572
treatment outcome (4376) 4376
risk factors (4268) 4268
angiotensin-converting enzyme inhibitors - adverse effects (4083) 4083
mortality (3971) 3971
adrenergic beta-antagonists - therapeutic use (3916) 3916
captopril (3788) 3788
drug therapy, combination (3776) 3776
medicine, general & internal (3772) 3772
blood-pressure (3747) 3747
angiotensin-converting enzyme inhibitors - administration & dosage (3714) 3714
heart failure (3697) 3697
hypertension - physiopathology (3554) 3554
renin-angiotensin system - drug effects (3439) 3439
converting enzyme-inhibitors (3264) 3264
ace inhibitors (3175) 3175
blood pressure (3111) 3111
urology & nephrology (2972) 2972
enalapril (2877) 2877
renin-angiotensin system (2831) 2831
time factors (2750) 2750
angiotensin-converting enzyme (2730) 2730
enzymes (2655) 2655
calcium channel blockers - therapeutic use (2613) 2613
hypertension - complications (2385) 2385
angiotensin receptor antagonists (2320) 2320
diuretics - therapeutic use (2308) 2308
aged, 80 and over (2307) 2307
captopril - pharmacology (2260) 2260
drug therapy (2241) 2241
angiotensin ii type 1 receptor blockers - therapeutic use (2168) 2168
double-blind method (2162) 2162
dose-response relationship, drug (2052) 2052
myocardial-infarction (2032) 2032
antihypertensive agents - pharmacology (2000) 2000
therapy (1999) 1999
heart failure - physiopathology (1942) 1942
follow-up studies (1851) 1851
enalapril - therapeutic use (1812) 1812
renin-angiotensin system - physiology (1802) 1802
care and treatment (1765) 1765
heart-failure (1752) 1752
prognosis (1752) 1752
randomized controlled trials as topic (1747) 1747
research (1745) 1745
retrospective studies (1739) 1739
risk (1738) 1738
clinical trials as topic (1724) 1724
angiotensin ii (1723) 1723
disease (1708) 1708
angiotensin converting enzyme (1697) 1697
prospective studies (1680) 1680
medicine & public health (1660) 1660
analysis (1655) 1655
enzyme inhibitors (1651) 1651
diabetes (1646) 1646
hemodynamics - drug effects (1615) 1615
captopril - therapeutic use (1585) 1585
peptidyl-dipeptidase a - metabolism (1547) 1547
bradykinin (1540) 1540
prevention (1522) 1522
kidney - drug effects (1505) 1505
angiotensin-converting enzyme inhibitor (1498) 1498
angiotensin converting enzyme inhibitors (1489) 1489
angiotensin receptor antagonists - therapeutic use (1487) 1487
rats, sprague-dawley (1485) 1485
converting enzyme-inhibition (1482) 1482
physiology (1458) 1458
health aspects (1437) 1437
myocardial infarction - drug therapy (1425) 1425
diuretics (1424) 1424
left-ventricular dysfunction (1424) 1424
angiotensin-ii (1405) 1405
rats, wistar (1405) 1405
converting-enzyme-inhibitor (1404) 1404
converting-enzyme-inhibitors (1395) 1395
disease progression (1394) 1394
proteinuria (1392) 1392
renin - blood (1392) 1392
enalapril - pharmacology (1390) 1390
expression (1380) 1380
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41938) 41938
German (1089) 1089
Japanese (1050) 1050
French (829) 829
Russian (734) 734
Spanish (447) 447
Italian (262) 262
Chinese (246) 246
Polish (211) 211
Portuguese (129) 129
Danish (86) 86
Hungarian (84) 84
Czech (78) 78
Dutch (76) 76
Swedish (63) 63
Norwegian (56) 56
Korean (33) 33
Finnish (30) 30
Romanian (26) 26
Slovak (25) 25
Hebrew (22) 22
Turkish (22) 22
Ukrainian (22) 22
Serbian (17) 17
Croatian (13) 13
Lithuanian (13) 13
Persian (6) 6
Bosnian (4) 4
Bulgarian (4) 4
Slovenian (3) 3
Belarusian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Medicine, ISSN 0025-7974, 08/2018, Volume 97, Issue 31, p. e11695
Rationale: Angiotensin-converting enzyme (ACE) inhibitors are one of the most used medication among patients with arterial hypertension. In most cases, ACE... 
angioedema | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | angiotensin-converting enzyme inhibitor side effects | adverse reaction | angiotensin-converting enzyme inhibitor | upper airways | Case studies | Development and progression | Angioneurotic edema | Care and treatment
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2018, Volume 71, Issue 13, pp. 1474 - 1482
Most guidelines for the management of patients with cardiovascular disease recommend angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy,... 
angioedema | blood pressure | heart failure | chronic kidney disease | left ventricular hypertrophy | angiotensin receptor blocker | coronary heart disease | adverse events | cough | diabetes | hypertension | CHRONIC HEART-FAILURE | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | RANDOMIZED-TRIALS | CARDIOVASCULAR EVENTS | VENTRICULAR SYSTOLIC FUNCTION | RECEPTOR BLOCKERS | ANTIHYPERTENSIVE EFFICACY | BLOOD-PRESSURE | ACE-INHIBITORS | HIGH-RISK | Angioedema - epidemiology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Hypertension - drug therapy | Renin-Angiotensin System - physiology | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Animals | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Angioedema - chemically induced | Renin-Angiotensin System - drug effects | Blood Pressure - drug effects | Blood Pressure - physiology | Cardiovascular Diseases - chemically induced | Clinical Trials as Topic - methods | Hypertension - epidemiology | Drug Therapy, Combination | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects | Heart | Heart failure | Hypertension | Medical colleges | Mortality | Coronary heart disease | Cardiovascular agents | Hospitals | Chronic kidney failure | Analysis | Cardiac patients | Angiotensin | Cardiology | ACE inhibitors | Myocardial infarction | Angiotensin-converting enzyme inhibitors | End-stage renal disease | Enzyme inhibitors | Peptidyl-dipeptidase A | Blood pressure | Drug therapy | Heart diseases | Cerebral infarction | Stroke | Angioedema | Risk analysis | Disease control | Patients | Inhibitors | Renal failure | Infarction | Kidney diseases | Diabetes | Cardiovascular diseases
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 1998, Volume 97, Issue 14, pp. 1411 - 1420
Journal Article